Autoclave treatment fails to completely inactivate DLB alpha-synuclein seeding activity

Goedert, 2013, 100 years of Lewy pathology, Nat. Rev. Neurol., 9, 13, 10.1038/nrneurol.2012.242 Steiner, 2018, The concept of alpha-synuclein as a prion-like protein: ten years after, Cell Tissue Res., 373, 161, 10.1007/s00441-018-2814-1 Prusiner, 1998, Prions, Proc. Nat. Acad. Sci. USA., 95, 13363, 10.1073/pnas.95.23.13363 Miake, 2002, Biochemical characterization of the core structure of alpha-synuclein filaments, J. Biol. Chem., 277, 19213, 10.1074/jbc.M110551200 Taylor, 1999, Inactivation of prions by physical and chemical means, J. Hosp. Infect., 43, S69, 10.1016/S0195-6701(99)90067-1 Tarutani, 2018, Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods, Acta Neuropathol. Commun., 6, 29, 10.1186/s40478-018-0532-2 Woerman, 2018, MSA prions exhibit remarkable stability and resistance to inactivation, Acta Neuropathol., 135, 49, 10.1007/s00401-017-1762-2 Wilham, 2010, Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays, PLoS Pathog., 6, 10.1371/journal.ppat.1001217 Fairfoul, 2016, Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies, Ann. Clin. Transl. Neurol., 3, 812, 10.1002/acn3.338 Groveman, 2018, Rapid and ultra-sensitive quantitation of disease-associated alpha-synuclein seeds in brain and cerebrospinal fluid by alphaSyn RT-QuIC, Acta Neuropathol. Commun., 6, 7, 10.1186/s40478-018-0508-2 Han, 2020, RT-QuIC-based detection of alpha-synuclein seeding activity in brains of dementia with Lewy Body patients and of a transgenic mouse model of synucleinopathy, Prion, 14, 88, 10.1080/19336896.2020.1724608 Ferreira, 2021, Detection of chronic wasting disease in mule and white-tailed deer by RT-QuIC analysis of outer ear, Sci. Rep., 11, 7702, 10.1038/s41598-021-87295-8 Pinder, 2021, Alpha-synuclein seeds of Parkinson's disease show high prion-exceeding resistance to steam sterilization, J. Hosp. Infect., 108, 25, 10.1016/j.jhin.2020.10.018 Ayers, 2022, Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy, Proc. Natl. Acad. Sci. U.S.A., 119, 10.1073/pnas.2113489119 Lau, 2020, α-Synuclein strains target distinct brain regions and cell types, Nat. Neurosci., 23, 21, 10.1038/s41593-019-0541-x Prusiner, 2015, Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism, Proc. Natl. Acad. Sci. U.S.A., 112, E5308, 10.1073/pnas.1514475112 Shahnawaz, 2020, Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy, Nature, 578, 273, 10.1038/s41586-020-1984-7 Jaunmuktane, 2019, Transmissible human proteopathies: an expanding field, Diagn. Histopathol., 25, 16, 10.1016/j.mpdhp.2018.11.002 Duyckaerts, 2019, The prion-like propagation hypothesis in Alzheimer's and Parkinson's disease, Curr. Opin. Neurol., 32, 266, 10.1097/WCO.0000000000000672 Asher, 2020, Risk of transmissibility from neurodegenerative disease-associated proteins: experimental knowns and unknowns, J. Neuropathol. Exp. Neurol., 79, 1141, 10.1093/jnen/nlaa109 Hamaguchi, 2022, Transmission of cerebral β-amyloidosis among individuals, Neurochem. Res., 47, 2469, 10.1007/s11064-022-03566-4 Lauwers, 2020, Potential human transmission of amyloid β pathology: surveillance and risks, Lancet Neurol., 19, 872, 10.1016/S1474-4422(20)30238-6 Taylor, 1997, Inactivation of transmissible degenerative encephalopathy agents: a review, Vet. J. (London, England, 159, 10, 10.1053/tvjl.1999.0406 Fichet, 2004, Novel methods for disinfection of prion-contaminated medical devices, Lancet, 364, 521, 10.1016/S0140-6736(04)16810-4 Peretz, 2006, Inactivation of prions by acidic sodium dodecyl sulfate, J. Virol., 80, 322, 10.1128/JVI.80.1.322-331.2006 Giles, 2008, Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation, PLoS Pathog., 4, 10.1371/journal.ppat.1000206 Hughson, 2016, Inactivation of prions and amyloid seeds with hypochlorous acid, PLoS Pathog., 12, 10.1371/journal.ppat.1005914